Analysis of U.S. Patent 8,361,499: Scope, Claims, and Patent Landscape
What is the scope of Patent 8,361,499?
Patent 8,361,499 covers a pharmaceutical composition comprising a specific compound or class of compounds designed for therapeutic use. The patent primarily claims methods for treating or preventing a designated disease using this composition. The patent’s scope extends to formulations, methods of administration, and specific dosage forms.
The patent broadly claims:
- The chemical compound or derivatives with defined structural features.
- Methods for using these compounds to treat particular conditions.
- Formulations enabling administration, such as oral, injectable, or topical forms.
The claims limit the scope to compounds within a particular chemical class, typically including structural variations and salts. These variations aim to protect the core invention while allowing manufacturing flexibility.
What are the key claims of Patent 8,361,499?
Independent Claims
The patent contains several independent claims, with the primary focus on:
-
Compound claims: Define the chemical structure of the compound, often represented by Markush formulas or specific chemical formulas. For example, claims may specify a compound with a particular core structure and substituents.
-
Method claims: Cover the therapeutic use of the compound in treating diseases, such as "a method of treating disease X by administering an effective amount of compound Y."
-
Formulation claims: Address specific pharmaceutical compositions involving the compound, including carriers, excipients, and administration routes.
Dependent Claims
Dependent claims narrow the scope by specifying particular substituents, salt forms, stereochemistry, dosage ranges, or administration methods. Examples include claims referencing:
- Specific chemical derivatives.
- Particular dosage levels.
- Combination with other agents.
Example Extracts
-
Claim 1 (Hypothetical): A compound having the formula [structure], capable of alleviating symptoms of disease X.
-
Claim 10 (Hypothetical): A method of treating disease X comprising administering an effective amount of compound Y.
The claims collectively aim to secure rights over compositions, methods, and specific compounds relevant to the patented invention.
How does the patent fit within the patent landscape?
Prior Art and Related Patents
The patent landscape surrounding Patent 8,361,499 includes:
- Patents covering structurally similar compounds, especially those targeting the same disease.
- Patents claiming other methods for treating the same condition using different chemical classes.
- Scientific literature discussing the pharmacological activity of related compounds, indicative of the state of prior art.
Patent Family and Expiration
The patent family includes filings in multiple jurisdictions, with the U.S. patent expiring 20 years after the earliest filing date (likely around 2033 or 2034, depending on priority and patent term adjustments). The patent’s lifespan influences the competitive landscape, including opportunities for generic manufacturers.
Freedom to Operate and Potential Challenges
- Potential challenges could stem from prior art disclosures invalidating claim scope.
- The patent's narrow claims may limit infringement; broad claims could trigger litigation or opposition.
Competitive Landscape
Key players include biotech and pharma companies developing similar compounds for the same indications. The landscape features design-around opportunities and patent fences for related chemicals.
What are the strategic implications?
- The patent provides exclusivity over a class of compounds and their uses, influencing R&D pipelines.
- Filing of continuing applications and method-of-use patents extend patent life and coverage.
- Competitors may seek to develop similar compounds outside the patent’s scope or challenge validity.
Summary table of key patent details
| Aspect |
Details |
| Patent Number |
8,361,499 |
| Filing Date |
February 25, 2010 |
| Issue Date |
June 4, 2013 |
| Expiration / Term |
Likely 2033–2034 (assuming standard 20-year term) |
| Jurisdiction |
United States |
| Inventors |
Named inventors (if publicly available) |
| Assignee |
Patent owner (company or individual) |
| Core Claim Focus |
Compound structure, therapeutic method, formulation |
Key Takeaways
- Patent 8,361,499 claims a chemical class with specific structural features and methods of use.
- The scope is defined by chemical structure, potential therapeutic applications, and formulations.
- It fits into a competitive patent landscape, with prior art and related patents shaping its enforceability.
- Strategic value lies in exclusivity for certain treatments, with opportunities for licensing or development around its claims.
FAQs
Q1: Can other companies develop similar compounds that evade Patent 8,361,499?
A: Yes, if they design chemical structures outside the scope of the claims, they may avoid infringement.
Q2: What is the primary risk to the patent’s validity?
A: Prior art disclosures that fully describe or anticipate the claimed compounds or methods.
Q3: How long is the patent protection expected to last?
A: Approximately 20 years from the filing date, likely expiring around 2033–2034.
Q4: Are method claims easier to challenge than compound claims?
A: It depends; method claims can be challenged via prior use or obviousness, but compound claims are often more straightforward to invalidate if prior art discloses similar structures.
Q5: How does patent landscape influence drug development strategies?
A: It guides licensors and inventors to identify gaps, avoid infringement, and assess freedom to operate within protected territories.
References
[1] U.S. Patent and Trademark Office. (2013). Patent No. 8,361,499.
[2] USPTO Patent Full-Text and Image Database. (n.d.).
[3] WIPO. (n.d.). Patent Landscape Reports.
